Unicycive Therapeutics's total assets for Q3 2025 were $50.61M, an increase of 68.73% from the previous quarter. UNCY total liabilities were $13.13M for the fiscal quarter, a -3.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.